Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PLECANATIDE vs POLATUZUMAB VEDOTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PLECANATIDE vs POLATUZUMAB VEDOTIN: Safety Overview

Metric PLECANATIDE POLATUZUMAB VEDOTIN
Total FAERS Reports 967 4,739
Deaths Reported 45 908
Death Rate 4.7% 19.2%
Hospitalizations 50 1,517
Average Patient Age 63.5 yrs 65.5 yrs
% Female Patients 75.4% 42.7%
FDA Approval Date Jan 19, 2017 N/A
Manufacturer Salix Pharmaceuticals Inc. Genentech, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription N/A